BCC
AMPH icon

Bridge City Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bridge City Capital’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.84M Buy
338,708
+3,603
+1% +$72.7K 1.56% 21
2026
Q1 		$6.56M Buy
335,105
+99,620
+42% +$2.44M 1.82% 13
2025
Q4 		$6.31M Buy
235,485
+99,227
+73% +$2.56M 1.85% 11
2025
Q3 		$3.63M Sell
136,258
-2,386
-2% -$61.6K 0.97% 40
2025
Q2 		$3.18M Buy
138,644
+22,789
+20% +$566K 0.89% 45
2025
Q1 		$3.36M Buy
115,855
+45,760
+65% +$1.46M 1.01% 40
2024
Q4 		$2.6M Sell
70,095
-984
-1% -$45K 0.69% 62
2024
Q3 		$3.45M Buy
71,079
+22,133
+45% +$971K 0.95% 43
2024
Q2 		$1.96M Buy
48,946
+14,173
+41% +$587K 0.66% 67
2024
Q1 		$1.53M Buy
34,773
+275
+0.8% +$14.2K 0.56% 83
2023
Q4 		$2.13M Buy
34,498
+11,839
+52% +$622K 0.83% 61
2023
Q3 		$1.04M Sell
22,659
-155
-0.7% -$8.46K 0.53% 84
2023
Q2 		$1.31M Buy
+22,814
New +$1.01M 0.62% 77

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bridge City Capital's AMPH Position: Q2 2026 in Review

Bridge City Capital increased its Amphastar Pharmaceuticals (AMPH) stake by 1.1% in Q2 2026, buying an estimated $72.7K and bringing the position to 338,708 shares worth $6.84M. The position accounts for 1.56% of the portfolio, ranked #21.

Bridge City Capital first reported a position in AMPH in Q2 2023 and has held it in 13 quarters since. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Bridge City Capital held 338,708 shares of Amphastar Pharmaceuticals worth $6.84M as of Q2 2026.
  • Bridge City Capital bought 3,603 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $72.7K.
  • Amphastar Pharmaceuticals made up 1.56% of Bridge City Capital's portfolio in Q2 2026, its #21 holding.
  • Bridge City Capital first reported a position in Amphastar Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Bridge City Capital's 13F filing for Q2 2026, filed 11 Aug 2026.